Investing.com - Merck reported on Thursday second quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Merck announced earnings per share of €1.99 on revenue of €5.57B. Analysts polled by Investing.com anticipated EPS of €2.49 on revenue of €5.42B.
Merck shares are down 18% from the beginning of the year, still down 19.76% from its 52 week high of €231.50 set on December 30, 2021. They are under-performing the DAX which is down 13.99% from the start of the year.
Merck follows other major Healthcare sector earnings this month
Merck's report follows an earnings missed by Siemens Healthineers on Wednesday, who reported EPS of €0.43 on revenue of €5.19B, compared to forecasts EPS of €0.4789 on revenue of €5.05B.
Bayer had beat expectations on Thursday with second quarter EPS of €1.93 on revenue of €12.82B, compared to forecast for EPS of €1.9 on revenue of €12.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar